Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of the National Cancer Institute

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9182979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

  2002cited by this paper
• Epidemiology of prostate cancer.

  1996cited by this paper
• The preventive role of diet in prostatic disease.

  1996cited by this paper
• Epidemiology, prevention and screening for prostate cancer.

  1996cited by this paper
• Role of dihydrotestosterone in androgen action

  1996cited by this paper
• The management of localised cancer of the prostate.

  1996cited by this paper
• Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

  1995cited by this paper
• Site‐specific Effects of Testosterone Propionate on the Prostate of Rat Pretreated with 3,2′‐Dimethyl‐4‐aminobiphenyl:Dose‐dependent Induction of Invasive Carcinomas

  1995cited by this paper
• FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.

  1995cited by this paper
• Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.

  1995cited by this paper
• FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.

  1995cited by this paper
• Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats.

  1994cited by this paper
• Cancer mortality in chinese immigrants to New York city. Comparison with chinese in tianjin and with United States‐born whites

  1994cited by this paper
• Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.

  1992cited by this paper
• Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

  1992cited by this paper
• Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.

  1992cited by this paper
• Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health.

  1992cited by this paper
• Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects.

  1991cited by this paper
• Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

  1991cited by this paper
• Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone.

  1990cited by this paper
• The promotional effect of testosterone on induction of prostate-cancer in MNU-sensitized L-W rats.

  1989cited by this paper
• Production, clearance, and metabolism of testosterone in men with prostatic cancer

  1987cited by this paper
• Serum testosterone levels in healthy young black and white men.

  1986cited by this paper
• Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.

  1984cited by this paper
• The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis.

  1984cited by this paper
• 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.

  1984cited by this paper
• Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.

  1981cited by this paper
• An improved method for extraction and determination of prostate concentrations of endogenous androgens.

  1978cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency.

  1977cited by this paper
• Selective Retention of Dihydrotestosterone by Prostatic Nuclei

  1968cited by this paper
• The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

  1968cited by this paper
• Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.

  1968cited by this paper

• A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers

  2017cites this paper
• Flaxseed Suppressed Prostatic Epithelial Proliferation in a Rat Model of Benign Prostatic Hyperplasia

  2015cites this paper
• Hormones and prostate carcinogenesis: Androgens and estrogens

  2011cites this paper
• 5α‐Reductase Isozymes and Androgen Actions in the Prostate

  2009cites this paper
• ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.

  2009cites this paper
• [Prostatic cancers].

  2007cites this paper
• Prostate cancer prevention

  2007cites this paper
• Regulation of prostate 5α‐reductase‐2 gene expression and prostate weight by dietary fat and caloric intake in the rat

  2006cites this paper
• Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells

  2006cites this paper
• Persistence of prostatic intraepithelial neoplasia after effective chemoprevention of microscopic prostate cancer with antiandrogen in a rat model.

  2006cites this paper
• Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: a model for prostate cancers in the aged.

  2005cites this paper
• Prostate carcinogenesis and inflammation: emerging insights.

  2005cites this paper
• Can animal models help us select specific compounds for cancer prevention trials?

  2005cites this paper
• Molecular Basis of Steroid Action in the Prostate.

  2005cites this paper
• 5α-Reductase Isozymes in the Prostate.

  2005cites this paper
• Prostate cancer chemoprevention: models, limitations and potential (Review).

  2004cites this paper
• Chemoprevention of carcinoma prostate. A review

  2004cites this paper
• Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate.

  2004cites this paper
• Agents in development for prostate cancer prevention

  2004cites this paper
• Prostate cancer prevention.

  2004cites this paper
• [Chemoprevention of prostatic cancer].

  2003cites this paper
• Chemoprevention of Prostate Carcinogenesis by DFMO and/or Finasteride Treatment in Male Wistar Rats

  2002cites this paper
• The potential for prostate cancer chemoprevention.

  2002cites this paper
• Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

  2002cites this paper
• Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components

  2002cites this paper
• The Future of Prostate Cancer Prevention

  2001cites this paper
• Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.

  2001cites this paper
• Potential agents for prostate cancer chemoprevention.

  2001cites this paper
• Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

  2001cites this paper
• Prostate cancer: a comprehensive review

  2000cites this paper
• Prostate cancer prevention trials in the USA.

  2000cites this paper
• Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.

  1999cites this paper
• Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.

  1998cites this paper
• Inhibitors of enzymes of androgen biosynthesis: cytochrome P450(17) alpha and 5 alpha-steroid reductase.

  1998cites this paper